Developmental exposure to valproate and ethanol alters locomotor activity and retino-tectal projection area in zebrafish embryos

Reproductive Toxicology

Volumn 33, Issue 2, 2012, Pages 165-173

  Cowden, John ^a   Padnos, Beth ^a   Hunter, Deborah ^a   MacPhail, Robert ^a   Jensen, Karl ^a   Padilla, Stephanie ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Brain development; Embryo; Ethanol; Locomotor activity; Retino tectal projection; Toxicity screening; Valproate; Zebrafish

Indexed keywords

ALCOHOL; VALPROIC ACID;

ANATOMICAL VARIATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO; FEMALE; LETHALITY; LOCOMOTION; MALE; NEUROTOXICITY; NONHUMAN; OPTIC TECTUM; RETINOTECTAL PROJECTION;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; EMBRYO, NONMAMMALIAN; ETHANOL; MOTOR ACTIVITY; RETINA; SUPERIOR COLLICULI; TERATOGENS; TOXICITY TESTS; VALPROIC ACID; ZEBRAFISH;

DANIO RERIO; MAMMALIA;

EID: 84858442380     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2011.11.111     Document Type: Article

References (65)

1. Barone S., Stanton M.E., Mundy W.R. Neurotoxic effects of neonatal triethyltin (TET) exposure are exacerbated with aging. Neurobiol Aging 1995, 16:723-735.
2. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y.W., et al. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J Neurosci 2005, 25:823-829.
3. Burbacher T.M., Grant K.S., Mayfield D.B., Gilbert S.G., Rice D.C. Prenatal methylmercury exposure affects spatial vision in adult monkeys. Toxicol Appl Pharmacol 2005, 208:21-28.
4. Hass U. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity. Reprod Toxicol 2006, 22:148-156.
5. Grandjean P., Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.
6. U.S. EPA. Health Effects Test Guidelines. OPPTS 870.6300. Developmental Neurotoxicity Study. In: Office of Prevention P, and Toxic Substances, editor. Washington, DC1998. p. 1-12.
7. NRC Toxicity Testing in the 21st Century: A Vision and A Strategy 2007, National Academies Press, p. 196. Council NR (Ed.).
8. Costa L.G., Fattori V., Giordano G., Vitalone A. An in vitro approach to assess the toxicity of certain food contaminants: methylmercury and polychlorinated biphenyls. Toxicology 2007, 237:65-76.
9. Padilla S., MacPhail R.C. Using zebrafish to assess developmental neurotoxicity. Reproductive and Developmental Toxicity 2011, 179-191. Elsevier Inc. R.C. Gupta (Ed.).
10. Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev Dyn 1995, 203:253-310.
11. den Hertog J. Chemical genetics: drug screens in Zebrafish. Biosci Rep 2005, 25:289-297.
12. Parng C., Seng W.L., Semino C., McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 2002, 1:41-48.
13. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
14. Kokel D., Bryan J., Laggner C., White R., Cheung C.Y., Mateus R., et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 2010, 6:231-237.
15. Kokel D., Peterson R.T. Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Brief Funct Genomic Proteomic 2008, 7:483-490.
16. Mathew L.K., Sengupta S., Kawakami A., Andreasen E.A., Lohr C.V., Loynes C.A., et al. Unraveling tissue regeneration pathways using chemical genetics. J Biol Chem 2007, 282:35202-35210.
17. Murphey R.D., Stern H.M., Straub C.T., Zon L.I. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des 2006, 68:213-219.
18. Ni-Komatsu L., Orlow S.J. Identification of novel pigmentation modulators by chemical genetic screening. J Invest Dermatol 2007, 127:1585-1592.
19. Peterson R.T., Link B.A., Dowling J.E., Schreiber S.L. Small molecule developmental screens reveal the logic and timing of vertebrate development. PNAS 2000, 97:12965-12969.
20. Yeh J.R., Crews C.M. Chemical genetics: adding to the developmental biology toolbox. Dev Cell 2003, 5:11-19.
21. Hill A.J., Teraoka H., Heideman W., Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005, 86:6-19.
22. Parng C. In vivo zebrafish assays for toxicity testing. Curr Opin Drug Discov Dev 2005, 8:100-106.
23. Teraoka H., Dong W., Hiraga T. Zebrafish as a novel experimental model for developmental toxicology. Congenit Anom (Kyoto) 2003, 43:123-132.
24. Ton C., Lin Y., Willett C. Zebrafish as a model for developmental neurotoxicity testing. Birth Defects Res (Part A) 2006, 76:553-567.
25. Fraysse B., Mons R., Garric J. Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicol Environ Saf 2006, 63:253-267.
26. Kaufmann W., Groters S. Developmental neuropathology in DNT-studies-a sensitive tool for the detection and characterization of developmental neurotoxicants. Reprod Toxicol 2006, 22:196-213.
27. Baier H., Klostermann S., Trowe T., Karlstrom R.O., Nusslein-Volhard C., Bonhoeffer F. Genetic dissection of the retinotectal projection. Development 1996, 123:415-425.
28. Bodick N., Levinthal C. Growing optic nerve fibers follow neighbors during embryogenesis. Proc Natl Acad Sci U S A 1980, 77:4374-4378.
29. Karlstrom R.O., Trowe T., Klostermann S., Baier H., Brand M., Crawford A.D., et al. Zebrafish mutations affecting retinotectal axon pathfinding. Development 1996, 123:427-438.
30. Trowe T., Klostermann S., Baier H., Granato M., Crawford A.D., Grunewald B., et al. Mutations disrupting the ordering and topographic mapping of axons in the retinotectal projection of the zebrafish, Danio rerio. Development 1996, 123:439-450.
31. MacPhail R.C., Peele D.B., Crofton K.M. Motor activity and screening for neurotoxicity. J Am College Toxicol 1989, 8:117-125.
32. NRC Environmental Neurotoxicology 1992, National Academy Press, Washington, D.C.
33. Cory-Slechta D.A., Crofton K.M., Foran J.A., Ross J.F., Sheets L.P., Weiss B., et al. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects. Environ Health Perspect 2001, 109(Suppl. 1):79-91.
34. National Research Council Environmental Neurotoxicology 1992, National Academy Press, Washington, D.C.
35. Raffaele K.C., Fisher J.E., Hancock S., Hazelden K., Sobrian S.K. Determining normal variability in a developmental neurotoxicity test: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol 2008, 30:288-325.
36. Christianson A.L., Chesler N., Kromberg J.G. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev Med Child Neurol 1994, 36:361-369.
37. Koren G., Nava-Ocampo A.A., Moretti M.E., Sussman R., Nulman I. Major malformations with valproic acid. Can Fam Physician 2006, 52:441-442. 4, 7.
38. Kostrouchova M., Kostrouch Z. Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol (Praha) 2007, 53:37-49.
39. Calhoun F., Warren K. Fetal alcohol syndrome: historical perspectives. Neurosci Biobehav Rev 2007, 31:168-171.
40. Costa L.G., Steardo L., Cuomo V. Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacol Rev 2004, 56:103-147.
41. MacPhail R.C., Brooks J., Hunter D.L., Padnos B., Irons T.D., Padilla S. Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 2009, 30:52-58.
42. Padilla S., Hunter D.L., Padnos B., Frady S., Macphail R.C. Assessing locomotor activity in larval zebrafish: influence of extrinsic and intrinsic variables. Neurotoxicol Teratol 2011.
43. Field H.A., Dong P.D., Beis D., Stainier D.Y. Formation of the digestive system in zebrafish II. Pancreas morphogenesis. Dev Biol 2003, 261:197-208.
44. Howard C.V., Reed M.G. Unbiased Stereology 1998, BIOS Scientific Publishers Limited, Oxford UK.
45. Dowling J.E. Fishing for Novel Genes 2002, American Philosophical Society, pp. 337-347.
46. Tukey J.W., Ciminera J.L., Heyse J.F. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 1985, 41:295-301.
47. Goldman D., Hankin M., Li Z., Dai X., Ding J. Transgenic zebrafish for studying nervous system development and regeneration. Transgenic Res 2001, 10:21-33.
48. Reimers M.J., Flockton A.R., Tanguay R.L. Ethanol- and acetaldehyde-mediated developmental toxicity in zebrafish. Neurotoxicol Teratol 2004, 26:769-781.
49. Loucks E., Carvan M.J. Strain-dependent effects of developmental ethanol exposure in zebrafish. Neurotoxicol Teratol 2004, 26:745-755.
50. Bilotta J., Barnett J.A., Hancock L., Saszik S. Ethanol exposure alters zebrafish development: a novel model of fetal alcohol syndrome. Neurotoxicol Teratol 2004, 26:737-743.
51. Blader P., Strähle U. Ethanol impairs migration of the prechordal plate in the zebrafish embryo. Dev Biol 1998, 201:185-201.
52. Carvan M.J., Loucks E., Weber D.N., Williams F.E. Ethanol effects on the developing zebrafish: neurobehavior and skeletal morphogenesis. Neurotoxicol Teratol 2004, 26:757-768.
53. Bilotta J., Saszik S., Givin C.M., Hardesty H.R., Sutherland S.E. Effects of embryonic exposure to ethanol on zebrafish visual function. Neurotoxicol Teratol 2002, 24:759-766.
54. Selderslaghs I.W., Van Rompay A.R., De Coen W., Witters H.E. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod Toxicol 2009, 28:308-320.
55. Zellner D., Padnos B., Hunter D.L., Macphail R.C., Padilla S. Rearing conditions differentially affect the locomotor behavior of larval zebrafish, but not their response to valproate-induced developmental neurotoxicity. Neurotoxicol Teratol 2011.
56. Zhang M.M., Xiao C., Yu K., Ruan D.Y. Effects of sodium valproate on synaptic plasticity in the CA1 region of rat hippocampus. Food Chem Toxicol 2003, 41:1617-1623.
57. Matsui J.I., Egana A.L., Sponholtz T.R., Adolph A.R., Dowling J.E. Effects of ethanol on photoreceptors and visual function in developing zebrafish. Invest Ophthalmol Vis Sci 2006, 47:4589-4597.
58. Fernandes Y., Gerlai R. Long-term behavioral changes in response to early developmental exposure to ethanol in zebrafish. Aging Clin Exp Res 2009, 33:601-609.
59. Herrmann K. Effects of the anticonvulsant drug valproic acid and related substances on the early development of the zebrafish (Brachydanio rerio). Toxic in Vitro 1993, 7:41-54.
60. Gurvich N., Berman M.G., Wittner B.S., Gentleman R.C., Klein P.S., Green J.B. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. FASEB J 2005, 19:1166-1168.
61. Dlugos C.A., Rabin R.A. Ocular deficits associated with alcohol exposure during zebrafish development. J Comp Neurol 2007, 502:497-506.
62. Kashyap B., Frederickson L.C., Stenkamp D.L. Mechanisms for persistent microphthalmia following ethanol exposure during retinal neurogenesis in zebrafish embryos. Vis Neurosci 2007, 24:409-421.
63. Kari G., Rodeck U., Dicker A.P. Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther 2007, 82:70-80.
64. Zon L.I. Zebrafish: a new model for human disease. Genome Res 1999, 9:99-100.
65. Parng C., Ton C., Lin Y.X., Roy N.M., McGrath P. A zebrafish assay for identifying neuroprotectants in vivo. Neurotoxicol Teratol 2006, 28:509-516.